{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T18:53:13Z","timestamp":1773341593089,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.bbamcr.2021.119160","type":"journal-article","created":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T14:28:24Z","timestamp":1633962504000},"page":"119160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Copper-imidazo[1,2-a]pyridines differentially modulate pro- and anti-apoptotic protein and gene expression in HL-60 and K562 leukaemic cells to cause apoptotic cell death"],"prefix":"10.1016","volume":"1869","author":[{"given":"Zeenat","family":"Ismail","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Dam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clement","family":"Penny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles B.","family":"de Koning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonie","family":"Harmse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbamcr.2021.119160_bb0005","doi-asserted-by":"crossref","unstructured":"Ferlay J, Colombet M, Soerjomataram I, Mathers C, Parkin DM, Pineros M, et al. (2019). Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int. J. Cancer 144(8): 1941\u20131953. doi: 19https:\/\/doi.org\/10.1002\/ijc.31937.","DOI":"10.1002\/ijc.31937"},{"issue":"9995","key":"10.1016\/j.bbamcr.2021.119160_bb0010","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","author":"Vos","year":"2015","journal-title":"Lancet."},{"key":"10.1016\/j.bbamcr.2021.119160_bb0015","doi-asserted-by":"crossref","unstructured":"Caldemeyer L, Akard LP (2016). Rationale and motivating factors for treatment-free remission in chronic myeloid leukemia. Leuk Lymphoma. 57(12):2739\u201351.doi:https:\/\/doi.org\/10.1080\/10428194.2016.1198959.","DOI":"10.1080\/10428194.2016.1198959"},{"key":"10.1016\/j.bbamcr.2021.119160_bb0020","series-title":"Goodman & Gilman\u2019s: The Pharmacological Basis of Therapeutics, 13e","article-title":"Pathway-targeted therapies: monoclonal antibodies, protein kinase inhibitors, and various small molecules","author":"Wellstein","year":"2017"},{"issue":"1","key":"10.1016\/j.bbamcr.2021.119160_bb0025","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12943-018-0780-6","article-title":"Chronic myeloid leukemia: the paradigm of targeting oncogenic tyrosine kinase signaling and counteracting resistance for successful cancer therapy","volume":"17","author":"Soverini","year":"2018","journal-title":"Mol. Cancer"},{"issue":"2","key":"10.1016\/j.bbamcr.2021.119160_bb0030","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1158\/1078-0432.CCR-13-0227","article-title":"Molecular pathways: targeting inhibitor of apoptosis proteins in Cancer\u2014from molecular mechanism to therapeutic application","volume":"20","author":"Fulda","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.bbamcr.2021.119160_bb0035","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2015.275","article-title":"Potential of apoptotic pathway-targeted cancer therapeutic research: where do we stand?","volume":"7","author":"Baig","year":"2016","journal-title":"Cell Death Dis."},{"issue":"1","key":"10.1016\/j.bbamcr.2021.119160_bb0040","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1021\/cr400135x","article-title":"Advances in copper complexes as anticancer agents","volume":"114","author":"Santini","year":"2014","journal-title":"Chem. Rev."},{"key":"10.1016\/j.bbamcr.2021.119160_bb0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.ica.2017.08.043","article-title":"Copper complexes as artificial DNA metallonucleases: from Sigman\u2019s reagent to next generation anti-cancer agent?","volume":"472","author":"McGivern","year":"2018","journal-title":"Inorg. Chim. Acta"},{"key":"10.1016\/j.bbamcr.2021.119160_bb0050","doi-asserted-by":"crossref","unstructured":"Ramachandran E, Gandin V, Bertani R, Sgarbossa P, Natarajan K, Bhuvanesh NSP, Venzo A, Zoleo A, Glisenti A, Dolmella A, Albinati A, Marzano C. (2018) Synthesis, characterization and cytotoxic activity of novel copper(II) complexes with aroylhydrazone derivatives of 2-Oxo-1,2-dihydrobenzo[h]quinoline-3-carbaldehyde. J Inorg Biochem.182:18\u201328. doi: https:\/\/doi.org\/10.1016\/j.jinorgbio.2018.01.016.","DOI":"10.1016\/j.jinorgbio.2018.01.016"},{"issue":"1","key":"10.1016\/j.bbamcr.2021.119160_bb0055","doi-asserted-by":"crossref","first-page":"13936","DOI":"10.1038\/s41598-017-13698-1","article-title":"Therapeutic potential of the phosphino cu(I) complex (HydroCuP) in the treatment of solid tumors","volume":"7","author":"Gandin","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbamcr.2021.119160_bb0060","doi-asserted-by":"crossref","unstructured":"Carcelli M, Tegoni M, Bartoli J, Marzano C, Pelosi G, Salvalaio M, Rogolino D, Gandin V. 2020) In vitro and in vivo anticancer activity of tridentate thiosemicarbazone copper complexes: Unravelling an unexplored pharmacological target. Eur J Med Chem.194:112266. doi: https:\/\/doi.org\/10.1016\/j.ejmech.2020.112266.","DOI":"10.1016\/j.ejmech.2020.112266"},{"key":"10.1016\/j.bbamcr.2021.119160_bb0065","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/med.20174","article-title":"Copper in diseases and treatments, and copper-based anticancer strategies","volume":"4","author":"Tisato","year":"2010","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.bbamcr.2021.119160_bb0070","doi-asserted-by":"crossref","unstructured":"Chang CJ (2015). Searching for harmony in transition-metal signaling. Nat. Chem. Biol. 11(10): 744\u2013747. doi: 7https:\/\/doi.org\/10.1038\/nchembio.1913.","DOI":"10.1038\/nchembio.1913"},{"key":"10.1016\/j.bbamcr.2021.119160_bb0075","doi-asserted-by":"crossref","unstructured":"Che M, Wang R, Li X, Wang H-Y, Zheng XFS (2016). Expanding roles of superoxide dismutases in cell regulation and cancer. Drug Discovery Today 21(1): 143-149. Drug Discov Today. 21(1):143-149. doi: https:\/\/doi.org\/10.1016\/j.drudis.2015.10.001.","DOI":"10.1016\/j.drudis.2015.10.001"},{"issue":"11","key":"10.1016\/j.bbamcr.2021.119160_bb0080","doi-asserted-by":"crossref","first-page":"4745","DOI":"10.1021\/jm500279x","article-title":"In vitro and in vivo anticancer activity of copper(I) complexes with homoscorpionate tridentate tris(pyrazolyl)borate and auxiliary monodentate phosphine ligands","volume":"57","author":"Gandin","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbamcr.2021.119160_bb0085","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ejmech.2016.10.041","article-title":"Synthesis of copper and zinc 2-(pyridin-2-yl)imidazo[1,2-a]pyridine complexes and their potential anticancer activity","volume":"126","author":"Dam","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bbamcr.2021.119160_bb0090","doi-asserted-by":"crossref","unstructured":"Zhao F, Wang W, Lu W, Xu L, Yang S, Cai X-M, et al. (2018). High anticancer potency on tumor cells of dehydroabietylamine Schiff-base derivatives and a copper(II) complex. Eur. J. Med. Chem. 146:451\u2013459. doi: https:\/\/doi.org\/10.1016\/j.ejmech.2018.01.041.","DOI":"10.1016\/j.ejmech.2018.01.041"},{"key":"10.1016\/j.bbamcr.2021.119160_bb0095","doi-asserted-by":"crossref","unstructured":"Hussain A, AlAjmi MF, Rehman MT, Amir S, Husain FM, Alsalme A, et al (2019). Copper(II) complexes as potential anticancer and nonsteroidal anti-inflammatory agents: in vitro and in vivo studies. Sci. Rep. 9, 5237. doi: https:\/\/doi.org\/10.1038\/s41598-019-41063-x.","DOI":"10.1038\/s41598-019-41063-x"},{"key":"10.1016\/j.bbamcr.2021.119160_bb0100","article-title":"Phase I study of one mixed chelates copper (II) compound, Casiope\u00edna CasIIIia with antitumor activity and its mechanism of action","author":"Ruiz-Azuara","year":"2014","journal-title":"AACR; Cancer Res. 74(19 Suppl): Abstract nr CT408."},{"key":"10.1016\/j.bbamcr.2021.119160_bb0105","doi-asserted-by":"crossref","unstructured":"Deep A, Bhatia RK, Kaur R, Kumar S, Jain UK, Singh H, et al. (2017). Imidazo[1,2-a]pyridine scaffold as prospective therapeutic agents. Curr Top Med Chem.17(2):238\u2013250. doi: https:\/\/doi.org\/10.2174\/1568026616666160530153233.","DOI":"10.2174\/1568026616666160530153233"},{"issue":"3","key":"10.1016\/j.bbamcr.2021.119160_bb0110","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.bmcl.2016.01.003","article-title":"Discovery of imidazo[1,2-a]-pyridine inhibitors of pan-PI3 kinases that are efficacious in a mouse xenograft model","volume":"26","author":"Han","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bbamcr.2021.119160_bb0115","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ejmech.2016.12.026","article-title":"Structure-based design and synthesis of imidazo[1,2-a]pyridine derivatives as novel and potent Nek2 inhibitors with in vitro and in vivo antitumor activities","volume":"126","author":"Xi","year":"2017","journal-title":"Eur. J. Med. Chem."},{"issue":"7\u20138","key":"10.1016\/j.bbamcr.2021.119160_bb0125","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s10495-019-01547-7","article-title":"Copper-imidazo[1,2-a]pyridines induce intrinsic apoptosis and modulate the expression of mutated p53, haem-oxygenase-1 and apoptotic inhibitory proteins in HT-29 colorectal cancer cells","volume":"24","author":"Harmse","year":"2019","journal-title":"Apoptosis."},{"key":"10.1016\/j.bbamcr.2021.119160_bb0130","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1472-6750-5-12","article-title":"A simple technique for quantifying apoptosis in 96-well plates","volume":"5","author":"Ribble","year":"2005","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.bbamcr.2021.119160_bb0135","series-title":"Advances in Mitochondrial Medicine","first-page":"157","article-title":"The mitochondrial pathways of apoptosis","author":"Estaquier","year":"2012"},{"key":"10.1016\/j.bbamcr.2021.119160_bb0140","doi-asserted-by":"crossref","unstructured":"Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394CT method. Methods.4:402\u20138. doi: https:\/\/doi.org\/10.1006\/meth.2001.1262.","DOI":"10.1006\/meth.2001.1262"},{"issue":"16","key":"10.1016\/j.bbamcr.2021.119160_bb0145","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1158\/1078-0432.CCR-16-1941","article-title":"Mitochondrial BAX determines the predisposition to apoptosis in human AML","volume":"23","author":"Reichenbach","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"3","key":"10.1016\/j.bbamcr.2021.119160_bb0150","doi-asserted-by":"crossref","DOI":"10.4081\/hr.2011.e28","article-title":"Clinical significance of P53 and Bcl-2 in acute myeloid leukemia patients of eastern India","volume":"3","author":"Sahu","year":"2011","journal-title":"Hematol. Rep."},{"issue":"51","key":"10.1016\/j.bbamcr.2021.119160_bb0155","doi-asserted-by":"crossref","first-page":"35532","DOI":"10.1074\/jbc.M807656200","article-title":"Caspase-mediated Bak activation and cytochrome c release during intrinsic apoptotic cell death in Jurkat cells","volume":"283","author":"Shawgo","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.bbamcr.2021.119160_bb0160","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.bbrc.2016.11.094","article-title":"Survivin does not influence the anti-apoptotic action of XIAP on caspase-9","volume":"482","author":"Zumbr\u00e4gel","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbamcr.2021.119160_bb0165","doi-asserted-by":"crossref","unstructured":"Rathore R, McCallum JE, Varghese E, Florea A-M, B\u00fcsselberg D (2017). Overcoming chemotherapy drug resistance by targeting inhibitors of apoptosis proteins (IAPs). Apoptosis 22(7):898\u2013919. doi: https:\/\/doi.org\/10.1007\/s10495-017-1375-1 22(7): 898\u2013919.","DOI":"10.1007\/s10495-017-1375-1"},{"issue":"3","key":"10.1016\/j.bbamcr.2021.119160_bb0170","doi-asserted-by":"crossref","first-page":"314","DOI":"10.7150\/jca.13332","article-title":"Survivin and tumorigenesis: molecular mechanisms and therapeutic strategies","volume":"7","author":"Chen","year":"2016","journal-title":"J. Cancer"},{"issue":"28","key":"10.1016\/j.bbamcr.2021.119160_bb0175","doi-asserted-by":"crossref","first-page":"25217","DOI":"10.18632\/oncotarget.4611","article-title":"Non genomic loss of function of tumor suppressors in CML: BCR-ABL promotes I\u03baB\u03b1 mediated p53 nuclear exclusion","volume":"6","author":"Crivellaro","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.bbamcr.2021.119160_bb0180","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12935-016-0326-1","article-title":"Survivin: a unique target for tumor therapy","volume":"16","author":"Garg","year":"2016","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbamcr.2021.119160_bb0185","doi-asserted-by":"crossref","unstructured":"Wheatley SP, Altieri DC (2019). Survivin at a glance. J. Cell Sci. 132(7):jcs223826. doi: https:\/\/doi.org\/10.1242\/jcs.223826.","DOI":"10.1242\/jcs.223826"},{"issue":"1","key":"10.1016\/j.bbamcr.2021.119160_bb0190","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S1476-5586(04)80051-4","article-title":"Upregulation of survivin in G2\/M cells and inhibition of caspase 9 activity enhances resistance in staurosporine-induced apoptosis","volume":"6","author":"Chandele","year":"2004","journal-title":"Neoplasia"},{"issue":"7","key":"10.1016\/j.bbamcr.2021.119160_bb0195","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1083\/jcb.201309107","article-title":"p53-mediated activation of the mitochondrial protease HtrA2\/Omi prevents cell invasion","volume":"204","author":"Yamauchi","year":"2014","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.bbamcr.2021.119160_bb0200","doi-asserted-by":"crossref","unstructured":"Datta SR, Katsov A, Hu L, Petros A, Fesik SW, Yaffe MB, et al. (2000). 14-3-3 proteins and survival kinases cooperate to inactivate BAD by BH3 domain phosphorylation. Mol. Cell 6(1):41\u201351 doi.https:\/\/doi.org\/10.1016\/S1097-2765(05)00012-2.","DOI":"10.1016\/S1097-2765(05)00012-2"},{"issue":"3","key":"10.1016\/j.bbamcr.2021.119160_bb0205","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/febs.14186","article-title":"Bax, Bak and beyond \u2014 mitochondrial performance in apoptosis","volume":"285","author":"Pe\u00f1a-Blanco","year":"2018","journal-title":"FEBS J."},{"issue":"1","key":"10.1016\/j.bbamcr.2021.119160_bb0210","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s10534-016-9983-8","article-title":"The mitochondrial apoptotic pathway is induced by Cu(II) antineoplastic compounds (Casiope\u00ednas\u00ae) in SK-N-SH neuroblastoma cells after short exposure times","volume":"30","author":"Garc\u00eda-Ramos","year":"2016","journal-title":"Biometals"},{"issue":"6","key":"10.1016\/j.bbamcr.2021.119160_bb0215","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/bjc.2015.85","article-title":"Mitochondrial apoptosis: killing cancer using the enemy within","volume":"112","author":"Lopez","year":"2015","journal-title":"Br. J. Cancer"},{"issue":"7","key":"10.1016\/j.bbamcr.2021.119160_bb0220","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1111\/febs.14659","article-title":"Autophagy and mitochondrial metabolism: insights into their role and therapeutic potential in chronic myeloid leukaemia","volume":"286","author":"Baquero","year":"2019","journal-title":"FEBS J."},{"issue":"9","key":"10.1016\/j.bbamcr.2021.119160_bb0225","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1158\/2326-6066.CIR-14-0112","article-title":"NF-\u03baB, an active player in human cancers","volume":"2","author":"Xia","year":"2014","journal-title":"Cancer Immunol Res."},{"issue":"6","key":"10.1016\/j.bbamcr.2021.119160_bb0230","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1002\/humu.22523","article-title":"How the TP53 family proteins TP63 and TP73 contribute to tumorigenesis: regulators and effectors","volume":"35","author":"Candi","year":"2014","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.bbamcr.2021.119160_bb0235","doi-asserted-by":"crossref","unstructured":"Hientz K, Mohr A, Bhakta-Guha D, Efferth T (2017). The role of p53 in cancer drug resistance and targeted chemotherapy. Oncotarget 8(5):8921\u201346. doi: 10.18632\/oncotarget.13475.","DOI":"10.18632\/oncotarget.13475"},{"key":"10.1016\/j.bbamcr.2021.119160_bb0240","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/s12885-016-2346-6","article-title":"The non-genomic loss of function of tumor suppressors: an essential role in the pathogenesis of chronic myeloid leukemia chronic phase","volume":"16","author":"Crivellaro","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.bbamcr.2021.119160_bb0245","doi-asserted-by":"crossref","unstructured":"Buccitelli C, Selbach M. (2020) mRNAs, proteins and the emerging principles of gene expression control. Nat Rev Genet. 21(10):630\u2013644. doi: https:\/\/doi.org\/10.1038\/s41576-020-0258-4.","DOI":"10.1038\/s41576-020-0258-4"},{"key":"10.1016\/j.bbamcr.2021.119160_bb0250","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/nature13319","article-title":"Mass-spectrometry-based draft of the human proteome","volume":"509","author":"Wilhelm","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.bbamcr.2021.119160_bb0255","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.cell.2016.03.014","article-title":"On the dependency of cellular protein levels on mRNA abundance","volume":"165","author":"Liu","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.bbamcr.2021.119160_bb0260","doi-asserted-by":"crossref","first-page":"10775","DOI":"10.1038\/srep10775","article-title":"Relationship between differentially expressed mRNA and mRNA-protein correlations in a xenograft model system","volume":"5","author":"Koussounadis","year":"2015","journal-title":"Sci. Rep."},{"issue":"7","key":"10.1016\/j.bbamcr.2021.119160_bb0265","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1177\/1947601910383011","article-title":"The unfolded protein response, degradation from the endoplasmic reticulum, and cancer","volume":"1","author":"Tsai","year":"2010","journal-title":"Genes Cancer"},{"key":"10.1016\/j.bbamcr.2021.119160_bb0270","doi-asserted-by":"crossref","unstructured":"Lynch M, Marinov GK. 2015 The bioenergetic costs of a gene. Proc Natl Acad Sci U S A. 112(51):15690\u20135. doi: https:\/\/doi.org\/10.1073\/pnas.1514974112.","DOI":"10.1073\/pnas.1514974112"},{"issue":"14","key":"10.1016\/j.bbamcr.2021.119160_bb0275","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1158\/1078-0432.CCR-16-3083","article-title":"Clinically relevant concentrations of anticancer drugs: a guide for nonclinical studies","volume":"23","author":"Liston","year":"2017","journal-title":"Clin. Cancer Res."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488921002147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167488921002147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T19:59:52Z","timestamp":1759089592000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167488921002147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S0167488921002147"],"URL":"https:\/\/doi.org\/10.1016\/j.bbamcr.2021.119160","relation":{},"ISSN":["0167-4889"],"issn-type":[{"value":"0167-4889","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Copper-imidazo[1,2-a]pyridines differentially modulate pro- and anti-apoptotic protein and gene expression in HL-60 and K562 leukaemic cells to cause apoptotic cell death","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbamcr.2021.119160","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"119160"}}